Learn More
Medchemexpress LLC Ansornitinib | 1448874-96-1 | 98.2% | 540.61 | 100 MG

Supplier: Medchemexpress LLC HY147243100MG
Ansornitinib is an orally active dual kinase inhibitor that inhibits platelet-derived growth factor receptor (PDGFR) and vascular endothelial growth factor receptor (VEGFR2). It can be used as an antifibrotic agent in lung, liver, kidney, and gastrointestinal fibrotic diseases.
- Orally active dual kinase inhibitor
- Inhibits platelet-derived growth factor receptor (PDGFR)
- Inhibits vascular endothelial growth factor receptor (VEGFR2)
- Functions as an antifibrotic agent
- Significantly inhibits phosphorylation of PDGFRβ and KDR
- Reduces inflammation and fibrosis markers
- Shown to reduce lung fibrosis in animal models
- Improves colonic histology in animal models
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.